Company Overview and News

17
Trade of the Day: General Motors Company (GM)

12h investorplace - 1
The stock indexes in China have been bright green since February, which is a bad thing. In China, a down day is shown as green on Chinese tickers and red is positive. The green has only gotten worse since U.S. exchanges went into the “red” at the beginning of October. Normally, it isn’t a good idea to equate a stock index with the economy. They are usually correlated, but not always.
F GM

14
The Tesla Model 3 Production Ramp Has Stalled Out

12h seekingalpha
Tesla's Model 3 production continues to stall; even with an early October jump, average weekly production is still well below 5,000.
GM

14
Uber IPO could put company value at $120B, report says

12h cbc.ca
Uber may put forth an initial public offering early next year that values the ride-hailing business at as much as $120 billion US, according to a media report.
TM TYT TOYOF 7203 MS GM

16
Will Ford's (F) Best-Seller F-Series Drive Q3 Earnings?

15h zacks
Ford Motor Company (F - Free Report) is scheduled to announce third-quarter 2018 results on Oct 24, before the market opens. In the last reported quarter, its bottom line missed the Zacks Consensus Estimate while automotive revenues marginally surpassed. In the past three months, shares of Ford have outperformed the industry it belongs to. During the period, the stock has lost 18.8% in comparison with the industry’s decline of 15.
BWA CTRL GM

14
Report: Uber IPO could put company value at $120 billion

15h nzherald.co.nz
NEW YORK (AP) — Uber may put forth an initial public offering early next year that values the ride-hailing business at as much as $120 billion, according to a media report.
MS GM

14
Report: Uber IPO could put company value at $120 B

16h business.inquirer.net
This March 20, 2018 file photo shows the Uber app on an iPad in Baltimore. Uber may put forth an initial public offering early next year that values the ride-hailing business at as much as $120 billion, according to a media report. AP
MS GM

22
The Wall Street Journal: Uber proposals double the company’s value at $120 billion in possible 2019 IPO

17h marketwatch
Uber has labored through a series of scandals, from claims of workplace sexual harassment to the alleged theft of trade secrets from rival Alphabet
TM GOOG GS GLSSP GM JBK GSC TFG TYT TOYOF GSJ GOOGL 7203 GJS

14
Court tosses DeLorean widow’s ‘Back to the Future’ lawsuit

20h entertainment.inquirer.net
This photo provided by Universal Pictures Home Entertainment shows Christopher Lloyd, left, as Dr. Emmett Brown, and Michael J. Fox as Marty McFly in the 1985 film, “Back to the Future.” A federal court has dismissed a lawsuit brought by the widow of automaker John DeLorean over royalties stemming from the “Back to the Future” movies. Sally DeLorean claimed a Texas company using the DeLorean name had illegally accepted royalties from Universal Pictures for the promotional use of images of the iconic car.
GM

23
Will Ford Stock’s Slump End Soon?

2018-10-15 investorplace
The price-book ratio of Ford’s (NYSE:F) stock is now about 1.0, significantly lower than its five-year average of 2.5, suggesting that Ford stock could be headed lower.
SHLD SCS F GM

61
7 Stocks That Should Rally With Fresh Blood

2018-10-15 investorplace
Do you think General Electric (NYSE:GE) should have fired its CEO? GE’s board did, letting John Flannery go after just 16 months in the job. On Flannery’s watch, GE stock lost 52% of its value and was booted off the Dow Jones after more than 100 years on the index.
IBM GE F GEC UL AAL SHLD NWL KHC GNE MS GM DHR IVZ

14
About 100,000 Opel vehicles to be recalled in diesel probe, says German ministry

2018-10-15 malaymail
FRANKFURT, Oct 16 — Germany's Transport Ministry said on yesterday it would order roughly 100,000 Opel vehicles to be recalled as part of an emissions probe, after prosecutors searched the carmaker's offices earlier in the day.
GM

14
Around 100,000 Opel vehicles to be recalled in diesel probe - ministry

2018-10-15 reuters
FRANKFURT (Reuters) - Germany’s Transport Ministry said on Monday it would order roughly 100,000 Opel vehicles to be recalled as part of an emissions probe, after prosecutors searched the carmaker’s offices earlier in the day.
GM

14
Around 100,000 Opel vehicles to be recalled in diesel probe - ministry

2018-10-15 channelnewsasia
German prosecutors and criminal investigators searched Opel sites in Ruesselsheim and Kaiserslautern as part of a probe into diesel exhaust emissions, German daily Bild said on Monday.
GM

14
Court tosses DeLorean widow's 'Back to the Future' lawsuit

2018-10-15 nzherald.co.nz
NEWARK, N.J. (AP) — A federal court has dismissed a lawsuit brought by the widow of automaker John DeLorean over royalties stemming from the "Back to the Future" movies.
GM

55
The Hidden Bear Market

2018-10-15 seekingalpha - 1
While the S&P 500 is still just 6% from its recent all-time high, a growing number of constituents are in bear market territory.
PCG SEE FB FBHS NEM LEN LB MAS DLTR NWL WHR AOS BEN CAH GM GEC GE PHM LKQ KHC GNE WRK

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 37045V134